EXETF - Extendicare: Growth Should Return Towards The End Of 2019
Investment Thesis
Extendicare (EXETF) [TSX:EXE] delivered another poor quarter with modest revenue growth and EBITDA margin compression. The company has several growth initiatives to expand its margins and grow its revenue. We believe Extendicare’s business should gradually improve towards the end of 2019, thanks to the implementation of its new enterprise resource planning system. However, its shares are fairly valued. Therefore, we think investors can wait on the sideline.
Data by YCharts
Recent Developments: Q1 2019 Highlights
Extendicare delivered poor Q1 2019 results. In the quarter, the company saw its revenue grew by